BETNEX is a cholinergic agonist primarily acting on muscarinic receptors of the urinary bladder and gastrointestinal tract.
How it works:
Bethanechol stimulates parasympathetic receptors, increasing the tone and contractility of the detrusor muscle. This promotes effective bladder emptying and reduces the risk of urinary retention. It has minimal action on nicotinic receptors, limiting systemic adverse effects.
Recommended for:
Clinical evidence:
Bethanechol has been used for decades in the management of functional urinary retention. Clinical studies demonstrate improved detrusor contractility after surgery and in neurogenic bladder disorders. Observational data confirm reductions in post-void residual urine volume and improvement in urodynamic parameters under medical supervision.
Indicated for urinary retention, bladder atony, and neurogenic bladder dysfunction. It works by stimulating muscarinic receptors, enhancing smooth muscle contraction and facilitating urination.
The medication is taken orally as prescribed by a healthcare provider. Dosage and duration depend on the severity of the condition and patient response. It is generally recommended to take the tablets on an empty stomach unless otherwise directed by a physician.
Contraindications
Side Effects
